Immediate Impact

1 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions
2024 Standout
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
3 intermediate papers

Works of B. Laffranchi being referenced

PD-0024 Phase I/II Study of Folfiri Plus the MEK1/2 Inhibitor Pimasertib (MSC1936369B) as Second-Line Treatment for KRAS Mutated Metastatic Colorectal Cancer
2012
A first in man, phase I dose-escalation study of PHA-793887, an inhibitor of multiple cyclin-dependent kinases (CDK2, 1 and 4) reveals unexpected hepatotoxicity in patients with solid tumors
2011

Author Peers

Author Last Decade Papers Cites
B. Laffranchi 221 100 176 159 18 406
Teresa Corral 164 24 41 234 15 430
T. Christopher Windham 178 35 69 203 14 435
Nicolas Papadopoulos 273 54 36 251 17 444
P. Schöffski 178 40 47 144 14 390
Naoto Nakamichi 98 89 15 168 22 358
N J Agnantis 214 21 33 164 24 417
Karl Hsu 168 101 31 254 13 428
Susan M. Kitchen-Goosen 120 30 36 223 18 444
Laura Quotti Tubi 113 118 39 272 21 405
Amy Camuso 164 161 23 112 12 398

All Works

Loading papers...

Rankless by CCL
2026